Drug Type Small molecule drug |
Synonyms Reminertant + [1] |
Target |
Mechanism NTSR1 antagonists(Neurotensin receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H31ClN4O5 |
InChIKeyDYLJVOXRWLXDIG-UHFFFAOYSA-N |
CAS Registry146362-70-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Meclinertant | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Extensive stage Small Cell Lung Cancer | Discovery | NL | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | RU | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | FR | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | MX | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | ES | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | BR | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | IT | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | HU | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | PL | 01 Oct 2002 | |
Extensive stage Small Cell Lung Cancer | Discovery | AR | 01 Oct 2002 |